Tagged as: HIV prevention
This year, researchers unveiled major interim results from two Phase 3 trials of injectable lenacapavir (LEN-LA). This new long-acting injectable, adm...
Find out moreMonday, 19 August, was World Humanitarian Day. The ‘polycrisis’ we are facing (security threats, global health challenges and climate change) is a...
Find out moreA policy brief on Female Genital Schistosomiasis (FGS), a neglected disease affecting up to 56 million women and girls, primarily in Sub-Saharan Afric...
Find out moreKey achievements and successes in the Global Fund Nadoum programme and a call-to-action for further investment in the region. ...
Find out moreLast week Frontline AIDS joined the 54th meeting of the UNAIDS Programme Coordinating Board to voice our concerns about the impact of anti-rights oppo...
Find out moreThe Annual Report and Accounts captures the performance and achievements of Frontline AIDS and our partnership in 2023....
Find out moreThis year, New York becomes the epicentre of global change, hosting two landmark events—the 57th Commission on Population and Development (CPD57) in...
Find out moreFrontline AIDS is deeply concerned by Uganda’s Constitutional Court decision not to overturn the Anti-Homosexuality Act, 2023, in its entirety....
Find out moreLast week’s launch of the Global HIV Prevention Coalition Prevention report shows significant progress, yet worrying gaps remain. ...
Find out more